Pacira Biosciences, Inc.
(NASDAQ : PCRX)

( )
PCRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -4.52%48.580.0%$711.87m
GWPHGW Pharmaceuticals Plc -0.28%214.256.1%$393.29m
HZNPHorizon Therapeutics Plc 0.38%90.915.5%$197.75m
JAZZJazz Pharmaceuticals Plc -1.58%168.042.3%$189.90m
VRXValeant Pharmaceuticals International, Inc. 0.58%31.4614.1%$185.11m
BHCBausch Health Cos., Inc. 0.58%31.460.0%$141.41m
CTLTCatalent, Inc. 1.07%113.452.1%$115.20m
ICLRICON plc -2.04%180.684.2%$96.12m
ARGXargenx SE -2.59%330.680.0%$81.80m
PRGOPerrigo Co. Plc -1.64%40.116.8%$71.31m
TNXPTonix Pharmaceuticals Holding Corp. -2.46%1.190.2%$66.62m
ZYNEZynerba Pharmaceuticals, Inc. 0.79%4.506.0%$58.84m
AMRNAmarin Corp. Plc -3.02%6.741.5%$49.30m
UTHRUnited Therapeutics Corp. -0.96%167.1814.1%$44.01m
PBHPrestige Consumer Healthcare, Inc. 0.12%41.824.0%$40.75m

Company Profile

Pacira Biosciences, Inc. develops and manufactures injectable therapeutic products. The firm engages in the development, commercialization and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.